Table of Contents Global Hormone Refractory Breast Cancer Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Hormone Refractory Breast Cancer Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Hormone Refractory Breast Cancer Segment by Type 1.2.1 Tumor Markers Therapy 1.2.2 Gene Expression Therapy 1.2.3 Gene Mutation Therapy 1.3 Market Analysis by Application 1.3.1 Scientific Research and Production 1.3.2 Biological Science and Technology 1.3.3 Medical Technology 1.3.4 Medical Apparatus and Instruments 1.4 Overview of Global Hormone Refractory Breast Cancer Market 1.4.1 Global Hormone Refractory Breast Cancer Revenue (2015-2025) 1.4.2 Global Hormone Refractory Breast Cancer Production and Capacity (2015-2025) 1.4.3 North America Hormone Refractory Breast Cancer Status and Prospect (2015-2025) 1.4.4 Europe Hormone Refractory Breast Cancer Status and Prospect (2015-2025) 1.4.5 Japan Hormone Refractory Breast Cancer Status and Prospect (2014-2025) 1.4.6 China Hormone Refractory Breast Cancer Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Hormone Refractory Breast Cancer Industry Impact 1.6.1 How the Covid-19 is Affecting the Hormone Refractory Breast Cancer Industry 1.6.2 Hormone Refractory Breast Cancer Business Impact Assessment - Covid-19 1.6.3 Market Trends and Hormone Refractory Breast Cancer Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Hormone Refractory Breast Cancer Market Competition by Manufacturer 2.1 Global Hormone Refractory Breast Cancer Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Hormone Refractory Breast Cancer Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Hormone Refractory Breast Cancer Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Hormone Refractory Breast Cancer Manufacturer Market Share 2.5 Top 10 Hormone Refractory Breast Cancer Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Hormone Refractory Breast Cancer Market 2.7 Key Manufacturers Hormone Refractory Breast Cancer Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Hormone Refractory Breast Cancer Industry Key Manufacturers 3.1 AstraZeneca 3.1.1 Company Details 3.1.2 Product Information 3.1.3 AstraZeneca Hormone Refractory Breast Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 AstraZeneca News 3.2 AmpliMed Corporation 3.2.1 Company Details 3.2.2 Product Information 3.2.3 AmpliMed Corporation Hormone Refractory Breast Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 AmpliMed Corporation News 3.3 Roche 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Roche Hormone Refractory Breast Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Roche News 3.4 Bluefish Pharmaceuticals AB 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Bluefish Pharmaceuticals AB Hormone Refractory Breast Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Bluefish Pharmaceuticals AB News 3.5 NeoCorp 3.5.1 Company Details 3.5.2 Product Information 3.5.3 NeoCorp Hormone Refractory Breast Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 NeoCorp News 3.6 Sanofi Genzyme 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Sanofi Genzyme Hormone Refractory Breast Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Sanofi Genzyme News 3.7 Neopharm 3.7.1 Company Details 3.7.2 Product Information 3.7.3 Neopharm Hormone Refractory Breast Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 Neopharm News 3.8 Boehringer Ingelheim GmbH 3.8.1 Company Details 3.8.2 Product Information 3.8.3 Boehringer Ingelheim GmbH Hormone Refractory Breast Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.8.4 Main Business Overview 3.8.5 Boehringer Ingelheim GmbH News 4 Global Hormone Refractory Breast Cancer Market Size Categorized by Regions (2015-2020) 4.1 Global Hormone Refractory Breast Cancer Sales Market Share by Region 4.2 Global Hormone Refractory Breast Cancer Revenue Market Share by Region (2015-2019) 4.3 Global Hormone Refractory Breast Cancer Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Hormone Refractory Breast Cancer Market Size Detail 4.4.1 North America Hormone Refractory Breast Cancer Sales Growth Rate (2015-2020) 4.4.2 North America Hormone Refractory Breast Cancer Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Hormone Refractory Breast Cancer Market Size Detail 4.5.1 Europe Hormone Refractory Breast Cancer Sales Growth Rate (2015-2020) 4.5.2 Europe Hormone Refractory Breast Cancer Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Hormone Refractory Breast Cancer Market Size Detail 4.6.1 Japan Hormone Refractory Breast Cancer Sales Growth Rate (2015-2020) 4.6.2 Japan Hormone Refractory Breast Cancer Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Hormone Refractory Breast Cancer Market Size Detail 4.7.1 China Hormone Refractory Breast Cancer Sales Growth Rate (2015-2020) 4.7.2 China Hormone Refractory Breast Cancer Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Hormone Refractory Breast Cancer Market Segment by Type 5.1 Global Hormone Refractory Breast Cancer Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Hormone Refractory Breast Cancer Sales and Market Share by Type (2015-2020) 5.1.2 Global Hormone Refractory Breast Cancer Revenue and Market Share by Type (2015-2020) 5.2 Tumor Markers Therapy Sales Growth Rate and Price 5.2.1 Global Tumor Markers Therapy Sales Growth Rate (2015-2020) 5.2.2 Global Tumor Markers Therapy Price (2015-2020) 5.3 Gene Expression Therapy Sales Growth Rate and Price 5.3.1 Global Gene Expression Therapy Sales Growth Rate (2015-2020) 5.3.2 Global Gene Expression Therapy Price (2015-2020) 5.4 Gene Mutation Therapy Sales Growth Rate and Price 5.4.1 Global Gene Mutation Therapy Sales Growth Rate (2015-2020) 5.4.2 Global Gene Mutation Therapy Price (2015-2020) 6 Global Hormone Refractory Breast Cancer Market Segment by Application 6.1 Global Hormone Refractory Breast Cancer Sales Market Share by Application (2015-2020) 6.2 Scientific Research and Production Sales Growth Rate (2015-2020) 6.3 Biological Science and Technology Sales Growth Rate (2015-2020) 6.4 Medical Technology Sales Growth Rate (2015-2020) 6.5 Medical Apparatus and Instruments Sales Growth Rate (2015-2020) 7 Hormone Refractory Breast Cancer Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Hormone Refractory Breast Cancer Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Hormone Refractory Breast Cancer Market Forecast 8.1 Global Hormone Refractory Breast Cancer Sales, Revenue Forecast 8.1.1 Global Hormone Refractory Breast Cancer Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Hormone Refractory Breast Cancer Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Hormone Refractory Breast Cancer Price and Trend Forecast (2020-2025) 8.2 Global Hormone Refractory Breast Cancer Sales Forecast by Region (2020-2025) 8.2.1 North America Hormone Refractory Breast Cancer Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Hormone Refractory Breast Cancer Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Hormone Refractory Breast Cancer Production, Revenue Forecast (2020-2025) 8.2.4 China Hormone Refractory Breast Cancer Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Hormone Refractory Breast Cancer Picture Table Global Hormone Refractory Breast Cancer Sales by Type Figure Global Sales Market Share of Hormone Refractory Breast Cancer by Product Type in 2019 Table Breakdown of Hormone Refractory Breast Cancer by Company Type (Tier 1, Tier 2 and Tier 3) Figure Hormone Refractory Breast Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Tumor Markers Therapy Picture Figure Gene Expression Therapy Picture Figure Gene Mutation Therapy Picture Table Global Hormone Refractory Breast Cancer Sales by Application Figure Global Hormone Refractory Breast Cancer Sales Market Share by Application in 2019 Figure Scientific Research and Production Picture Figure Biological Science and Technology Picture Figure Medical Technology Picture Figure Medical Apparatus and Instruments Picture Table Hormone Refractory Breast Cancer Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Hormone Refractory Breast Cancer Revenue (Million US$) (2015-2025) Figure Global Hormone Refractory Breast Cancer Production (K Units) (2015-2025) Figure North America Hormone Refractory Breast Cancer Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Hormone Refractory Breast Cancer Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Hormone Refractory Breast Cancer Revenue (Million US$) Growth Rate (2014-2025) Figure China Hormone Refractory Breast Cancer Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Hormone Refractory Breast Cancer Sales by Manufacturer (2018-2020) Figure Global Hormone Refractory Breast Cancer Sales Market Share by Manufacturer in 2019 Table Global Hormone Refractory Breast Cancer Revenue by Manufacturer (2018-2020) Figure Global Hormone Refractory Breast Cancer Revenue Market Share by Manufacturer in 2019 Table Global Hormone Refractory Breast Cancer Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Hormone Refractory Breast Cancer Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Hormone Refractory Breast Cancer Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Hormone Refractory Breast Cancer Market Table Key Manufacturers Hormone Refractory Breast Cancer Product Type Table Mergers & Acquisitions Planning Table AstraZeneca Company Profile Figure Hormone Refractory Breast Cancer Product Picture and Specifications of AstraZeneca Table Hormone Refractory Breast Cancer Production, Price, Revenue and Gross Margin of 2018-2020 Figure AstraZeneca Hormone Refractory Breast Cancer Market Share (2018-2020) Table AstraZeneca Main Business Table AstraZeneca Recent Development Table AmpliMed Corporation Company Profile Figure Hormone Refractory Breast Cancer Product Picture and Specifications of AmpliMed Corporation Table Hormone Refractory Breast Cancer Production, Price, Revenue and Gross Margin of 2018-2020 Figure AmpliMed Corporation Hormone Refractory Breast Cancer Market Share (2018-2020) Table AmpliMed Corporation Main Business Table AmpliMed Corporation Recent Development Table Roche Company Profile Figure Hormone Refractory Breast Cancer Product Picture and Specifications of Roche Table Hormone Refractory Breast Cancer Production, Price, Revenue and Gross Margin of 2018-2020 Figure Roche Hormone Refractory Breast Cancer Market Share (2018-2020) Table Roche Main Business Table Roche Recent Development Table Bluefish Pharmaceuticals AB Company Profile Figure Hormone Refractory Breast Cancer Product Picture and Specifications of Bluefish Pharmaceuticals AB Table Hormone Refractory Breast Cancer Production, Price, Revenue and Gross Margin of 2018-2020 Figure Bluefish Pharmaceuticals AB Hormone Refractory Breast Cancer Market Share (2018-2020) Table Bluefish Pharmaceuticals AB Main Business Table Bluefish Pharmaceuticals AB Recent Development Table NeoCorp Company Profile Figure Hormone Refractory Breast Cancer Product Picture and Specifications of NeoCorp Table Hormone Refractory Breast Cancer Production, Price, Revenue and Gross Margin of 2018-2020 Figure NeoCorp Hormone Refractory Breast Cancer Market Share (2018-2020) Table NeoCorp Main Business Table NeoCorp Recent Development Table Sanofi Genzyme Company Profile Figure Hormone Refractory Breast Cancer Product Picture and Specifications of Sanofi Genzyme Table Hormone Refractory Breast Cancer Production, Price, Revenue and Gross Margin of 2018-2020 Figure Sanofi Genzyme Hormone Refractory Breast Cancer Market Share (2018-2020) Table Sanofi Genzyme Main Business Table Sanofi Genzyme Recent Development Table Neopharm Company Profile Figure Hormone Refractory Breast Cancer Product Picture and Specifications of Neopharm Table Hormone Refractory Breast Cancer Production, Price, Revenue and Gross Margin of 2018-2020 Figure Neopharm Hormone Refractory Breast Cancer Market Share (2018-2020) Table Neopharm Main Business Table Neopharm Recent Development Table Boehringer Ingelheim GmbH Company Profile Figure Hormone Refractory Breast Cancer Product Picture and Specifications of Boehringer Ingelheim GmbH Table Hormone Refractory Breast Cancer Production, Price, Revenue and Gross Margin of 2018-2020 Figure Boehringer Ingelheim GmbH Hormone Refractory Breast Cancer Market Share (2018-2020) Table Boehringer Ingelheim GmbH Main Business Table Boehringer Ingelheim GmbH Recent Development Table Global Hormone Refractory Breast Cancer Sales (K Units) by Region (2015-2020) Table Global Hormone Refractory Breast Cancer Sales Market Share by Region (2015-2019) Figure Global Hormone Refractory Breast Cancer Sales Market Share by Region (2015-2019) Figure Global Hormone Refractory Breast Cancer Sales Market Share by Region in 2018 Table Global Hormone Refractory Breast Cancer Revenue (Million US$) by Region (2015-2020) Table Global Hormone Refractory Breast Cancer Revenue Market Share by Region (2015-2020) Figure Global Hormone Refractory Breast Cancer Revenue Market Share by Region (2015-2020) Figure Global Hormone Refractory Breast Cancer Revenue Market Share by Region in 2019 Table Global Hormone Refractory Breast Cancer Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Hormone Refractory Breast Cancer Sales (K Units) Growth Rate (2015-2020) Figure Europe Hormone Refractory Breast Cancer Sales (K Units) Growth Rate (2015-2020) Table Europe Hormone Refractory Breast Cancer Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Hormone Refractory Breast Cancer Sales (K Units) Growth Rate (2015-2020) Table Japan Hormone Refractory Breast Cancer Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Hormone Refractory Breast Cancer Sales (K Units) Growth Rate (2015-2020) Table China Hormone Refractory Breast Cancer Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Hormone Refractory Breast Cancer Sales by Type (2015-2020) Table Global Hormone Refractory Breast Cancer Sales Market Share by Type (2015-2020) Figure Global Hormone Refractory Breast Cancer Sales Market Share by Type in 2019 Table Global Hormone Refractory Breast Cancer Revenue by Type (2015-2020) Table Global Hormone Refractory Breast Cancer Revenue Market Share by Type (2015-2020) Figure Global Hormone Refractory Breast Cancer Revenue Market Share by Type in 2019 Figure Global Tumor Markers Therapy Sales Growth Rate (2015-2025) Figure Global Tumor Markers Therapy Price (2015-2020) Figure Global Gene Expression Therapy Sales Growth Rate (2015-2025) Figure Global Gene Expression Therapy Price (2015-2020) Figure Global Gene Mutation Therapy Sales Growth Rate (2015-2025) Figure Global Gene Mutation Therapy Price (2015-2020) Table Global Hormone Refractory Breast Cancer Sales Market Share by Application (2015-2020) Figure Global Hormone Refractory Breast Cancer Sales Market Share by Application in 2019 Figure Global Scientific Research and Production Sales Growth Rate (2015-2025) Figure Global Biological Science and Technology Sales Growth Rate (2015-2025) Figure Global Medical Technology Sales Growth Rate (2015-2025) Figure Global Medical Apparatus and Instruments Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Hormone Refractory Breast Cancer Table Key Players of Downstream Markets Figure Sales Channel Figure Global Hormone Refractory Breast Cancer Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Hormone Refractory Breast Cancer Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Hormone Refractory Breast Cancer Price and Trend Forecast (2020-2025) Table Global Hormone Refractory Breast Cancer Sales (K Units) Forecast by Region (2020-2025) Figure Global Hormone Refractory Breast Cancer Production Market Share Forecast by Region (2020-2025) Figure North America Hormone Refractory Breast Cancer Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Hormone Refractory Breast Cancer Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Hormone Refractory Breast Cancer Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Hormone Refractory Breast Cancer Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Hormone Refractory Breast Cancer Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Hormone Refractory Breast Cancer Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Hormone Refractory Breast Cancer Production (K Units) Growth Rate Forecast (2020-2025) Figure China Hormone Refractory Breast Cancer Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

AstraZeneca AmpliMed Corporation Roche Bluefish Pharmaceuticals AB NeoCorp Sanofi Genzyme